Advertisement

Latest Articles in lupin

Vinita Gupta: Always On The Move

Vinita knew exactly what she wanted to do when she joined Lupin. To take IT global and enter the largest, most advanced, and regulated pharma market, the US

Read More

Lupin Q3 Profit Up 21%, Beats Estimate

Lupin Ltd reported a 21 per cent jump in its quarterly profit, beating analysts' estimates, helped by higher sales of its diabetes products in the United States

Read More

Lupin, Eli Lilly Expand Partnership In India

Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import

Read More

Lupin Gets US Nod To Market Tablets Used For Treatment Of HIV Virus

According to a company statement, tentative approval was received for Abacavir Sulfate and Lamivudine tablets

Read More

Lupin Q2 Profit Lags As Costs Rise

Lupin, the world's seventh-largest generic drugmaker, said North America sales rose 73.1 percent to about 20 billion rupees

Read More

Lupin Quarterly Profit Gets Boost From Lower Tax Rate

Sales in North America, Lupin's largest market, surged 82.3 per cent, helped by sales of products bought via the acquisition of Gavis in July, and higher sales of its generic version of diabetes drug Glumetza

Read More

Lupin Buys 21 Generic Brands From Shionogi In Japanese Market

Under the terms of this agreement, Kyowa will book the sales of the 21 products after December 1, 2016, and Shionogi will receive 15.4 billion yen from Kyowa

Read More

Lupin To Buy 21 Branded Drugs From Japan's Shionogi

The portfolio will be transferred to Lupin on Dec. 31, subject to regulatory approvals and certain closing conditions, the companies said

Read More

Market Consolidates As Sensex Creeps Up, Lupin Leads

Market remained in a phase of consolidation as the Sensex edged up 35 points in choppy trade on Thursday ahead of start of earnings season next week and Monsoon session of Parliament amid a higher opening in Europe

Read More

Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More

Pharmaceutical Sector Grows 12 Per Cent In February: Report

Domestic companies grew at a modest pace of 14 per cent as against 19.4 per cent in the same period last year, and an average of 13.3 per cent since April 2015

Read More

US, EU Regulators Urge Indian Drug Companies To Step Up Standards

India supplies about 33 per cent of the medicines sold in the United States, and nearly a quarter sold in the UK

Read More

Sensex Extends Gains For 2nd Day, Up 278 Points On Value-buying

The Sensex rose for a second straight day by surging over 278 points, led by a rally in recently beaten-down bluechip stocks, trimming weekly loss amid mixed Asian cues and a better start in Europe and firm US index futures ahead of jobs data

Read More